[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100555542":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":7,"responsibleParty":20,"collaborators":7,"id":22,"slug":23,"hasResults":24,"nctId":25,"briefTitle":26,"officialTitle":26,"acronym":27,"eligibilityCriteria":28,"healthyVolunteers":29,"sex":30,"minAge":31,"maxAge":7,"enrollmentInfo":32,"targetDuration":7,"studyType":35,"phases":7,"briefSummary":36,"conditions":37,"keywords":7,"overallStatus":39,"whyStopped":7,"lastUpdateSubmitDate":40,"lastUpdatePostDateStruct":41,"startDateStruct":44,"completionDateStruct":46,"leadSponsor":48,"locationsCount":7},{"fullName":5,"class":6},"Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust","OTHER_GOV",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"OTHER","Trabecular bone score software","To assess the clinical utility of trabecular bone score (TBS) on fracture risk prediction including the new version (TBS V4) and future TBS versions at the spine and hip.",[14],{"name":15,"role":16,"phone":17,"phoneExt":18,"email":19},"Claire Mennan, PhD","CONTACT","0169140","4699","claire.mennan@nhs.net",{"type":21,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100555542","the-added-value-of-bone-microstructure-assessment-in-the-management-of-osteoporotic-bone-100555542",false,"NCT06513442","The Added Value of Bone Microstructure Assessment in the Management of Osteoporotic Bone","ADVANTAGE BONE","Inclusion Criteria: Has had a DEXA scan\n\n* Has had a DEXA scan\n\nExclusion Criteria:\n\n* Unable to complete DEXA scan",true,"ALL","18 Years",{"count":33,"type":34},1500,"ESTIMATED","OBSERVATIONAL","1. To assess the clinical utility of trabecular bone score (TBS) on fracture risk prediction including the new version (TBS V4) and future TBS versions at the spine and hip.\n2. To assess the clinical utility of TBS software as a potential treatment outcome: sensitivity to change over time and following osteoporosis therapy.\n3. To compare TBS to other imaging modalities of bone structure such as quantitative computed tomography (QCT) in fracture risk prediction and response to osteoporosis therapy.",[38],"Osteoporosis","NOT_YET_RECRUITING","2024-07-17",{"date":42,"type":43},"2024-07-22","ACTUAL",{"date":45,"type":34},"2024-08-01",{"date":47,"type":34},"2034-08-01",{"name":5,"class":6}]